G-CSF对Alzheimer病模型大鼠的治疗及其相关凋亡因子的影响
本文选题:阿尔茨海默病 + 粒细胞集落刺激因子 ; 参考:《吉林大学》2012年硕士论文
【摘要】:阿尔茨海默病(Alzheimer disease,AD)是一种老年人常见的神经系统变性疾病。AD的典型组织病理学特征为老年斑、神经元纤维缠结及神经元缺失。其起病隐袭,发病早期不易被发现,临床上常呈持续进展的智能减退,多伴人格障碍。在发达国家,AD是位于心脏病、肿瘤及中风之后的第四位致死性疾病,随年龄的逐渐增长,患者量的不断增加势必会给社会及家庭带来更大的负担。如何有效地治疗AD已成为社会广泛关注的问题。目前AD的病因及发病机制尚未阐明,亦无特效的治疗办法。细胞凋亡与AD的发生、发展密切相关。粒细胞集落刺激因子(G-CSF)具有促进增殖分化、抗凋亡、抗炎等作用。近年来发现在脑缺血动物模型的治疗实验中,G-CSF具有神经保护作用。但目前用于治疗AD的研究较少。本实验旨在观察G-CSF对AD模型大鼠的治疗作用及其对相关凋亡因子的影响。为AD的治疗研究提供有益的帮助。 本实验大体步骤如下,(1)首先用Morris水迷宫筛选反应迅速、活跃的Wistar雄性大鼠30只,体重250~300g,鼠龄3-4个月,分笼喂养。(2)随机分为三组:正常组,模型对照组,G-CSF治疗组。每组10只。(3)参照大鼠脑立体定位图谱,应用大鼠脑立体定向仪切除双侧穹窿-海马伞制备AD大鼠模型。(4)术后第14天开始连续5天行Morris水迷宫定位航行训练,记录逃避潜伏期成绩,取5天内的平均数,以期模型对照组及G-CSF治疗组明显高于正常组,证明建模成功。(5)建模成功后,正常组及模型对照组向每只大鼠腹腔注射0.3ml/kg·d磷酸盐缓冲液(PBS),G-CSF治疗组给予每只大鼠腹腔注射50ug(0.3ml)/kg·d G-CSF,均连续注射7天。从给药第1天起,用药后第10天开始再次行Morris水迷宫训练,前5天进行定位航行实验,记录各组5天内逃避潜伏期成绩,取平均数。最后一天撤除平台,行空间探索实验,记录各组目的象限游泳距离百分比。(6)测试完成后处死三组大鼠,灌注取脑,制备石蜡切片,行HE染色观察各组大鼠脑组织病理改变,应用免疫组化方法检测各组脑皮质及海马区凋亡因子Bcl-2、Caspase-3的变化。(7)采集图像,免疫阳性细胞数计数,,整理数据,所有数据采用SPSS11.0统计学软件进行处理,以均数±标准差(x±s)表示,采用方差分析及两两比较t检验进行数据分析,P0.05表示差异具有统计学意义。 结果显示,(1)术后14天进行的连续5天Morris水迷宫实验结果表明,模型对照组及G-CSF治疗组与正常组相比,其逃避潜伏期均明显延长(P0.01);模型对照组与G-CSF治疗组比较逃避潜伏期,差异不具有统计学意义(P0.05),证明建模成功。(2)给予G-CSF治疗后第10天开始再次连续5天行Morris水迷宫训练,正常组与模型对照组相比,逃避潜伏期明显缩短(P0.01),正常组与G-CSF治疗组之间相比,逃避潜伏期明显缩短(P0.05),G-CSF治疗组与模型对照组相比,逃避潜伏期明显缩短(P0.05)。最后一天行空间探索实验,记录目的象限游泳距离百分比(目的象限百分比),正常组与模型对照组相比,目的象限百分比明显延长(P0.01),G-CSF治疗组与模型对照组相比,目的象限百分比明显延长(P0.05),正常组与G-CSF治疗组相比,目的象限百分比明显延长(P0.05)。(3)大鼠脑组织各区病理学超微结构观察:常规HE染色,正常组皮层、海马等结构完整,形态正常,细胞排列整齐,分布均匀。G-CSF治疗组皮层、海马等处可见少量胶质细胞增生,细胞凋亡改变少见。模型对照组皮层神经细胞损坏明显,可见大量散在的单个固缩凋亡细胞;海马锥体细胞带变稀、紊乱、中断,同时可见多个细胞体积缩小,胞质浓染,胞核固缩。(4)用免疫组化方法测定大鼠皮层及海马CA1区凋亡因子Bcl-2及Caspase-3的表达,分别计数阳性反应细胞数,阳性反应为胞浆呈黄色到棕褐色,有时也可见于胞膜和胞核。模型对照组与正常组相比,皮层及海马CA1区Bcl-2表达明显减少(P0.05),Caspase-3的表达明显增加(P0.05);G-CSF治疗组与模型对照组相比,皮层及海马CA1区Bcl-2表达明显增加(P0.05),Caspase-3的表达明显减少(P0.05)。 综上,本研究说明,G-CSF对切除双侧穹窿-海马伞制备的AD模型大鼠具有治疗作用,可以在一定程度上改善模型大鼠的认知障碍,而G-CSF通过上调皮层及海马区Bcl-2表达、下调Caspase-3表达的抗凋亡机制参与了对AD模型大鼠的这种治疗作用。
[Abstract]:Alzheimer disease (AD) is a common type of neurodegenerative disease of the elderly, the typical histopathological features of.AD, the senile plaques, neurofibrillary tangles and neuronal loss. AD is the fourth fatal disease after heart disease, tumor and stroke. With the increase of age, the increasing amount of patients will bring greater burden to society and family. How to effectively treat AD has become a widespread concern. At present, the etiology and pathogenesis of AD have not yet been clarified, and there is no special treatment. Method. Apoptosis is closely related to the development of AD. Granulocyte colony stimulating factor (G-CSF) has the role of promoting proliferation, differentiation, anti apoptosis and anti-inflammatory. In recent years, it has been found that G-CSF has neuroprotective effect in the treatment experiments of cerebral ischemia animal models. However, there are few studies on the treatment of AD at present. The aim of this experiment is to observe the AD model of G-CSF. The therapeutic effect of the rat and its effect on the related apoptosis factors will provide useful help for the research and treatment of AD.
The main steps of this experiment were as follows: (1) first, 30 male rats with rapid and active reaction were screened by Morris water maze, with a weight of 250 to 300g and 3-4 months of age for 3-4 months. (2) they were randomly divided into three groups: normal group, model control group, G-CSF treatment group, 10 rats in each group. (3) the rat brain stereotaxic atlas was applied to the stereotaxis of rat brain. AD rat model was prepared by bilateral fornix fornix parachute. (4) Morris water maze navigation training was performed on the fourteenth day after 5 days, and the average number of escape latency was recorded in 5 days. The model control group and the G-CSF treatment group were obviously higher than the normal group. (5) the normal group and the model control group after the successful modeling were successful. Each rat was intraperitoneally injected with 0.3ml/kg D phosphate buffer solution (PBS). The rats in the G-CSF treatment group were given 50ug (0.3ml) /kg. D G-CSF in each rat for 7 days. From the first day of the administration, the training of the Morris water maze was repeated on the tenth day after the drug administration, and the fixed navigation experiment was carried out on the first 5 days, and the escape latency was recorded in each group for 5 days, and the results of the escape latency were recorded in each group. The average number. In the last day, the platform was removed and the space exploration experiment was carried out to record the percentage of swimming distance in each group. (6) after the test was completed, three groups of rats were killed, the brain was perfused and the paraffin section was prepared. HE staining was used to observe the pathological changes in the brain tissue of each group, and the apoptosis factor Bcl-2 in the cortex and hippocampus of each group was detected by immunohistochemical method, C The change of aspase-3. (7) collect the image, count the number of immunoreactive cells, arrange the data, all the data are processed by SPSS11.0 statistics software, the mean number of standard deviation (x + s), analysis of variance and 22 comparison t test for data analysis, P0.05 indicates that difference has statistical significance.
The results showed that (1) the results of the 5 day Morris water maze test on the 14 day after the operation showed that the escape latency of the model control group and the G-CSF treatment group was significantly longer than that of the normal group (P0.01), and the model control group was compared with the G-CSF treatment group, and the difference was not statistically significant (P0.05), which proved that the modeling was successful. (2) G-CSF After tenth days after treatment, the Morris water maze was trained again for 5 days. The escape latency was significantly shortened (P0.01) in the normal group compared with the model control group. The escape latency was significantly shortened (P0.05) in the normal group compared with the G-CSF treatment group. The escape latency was significantly shortened (P0.05) in the G-CSF treatment group compared with the model control group. The last day was empty. Between the normal group and the model control group, the percentage of the target quadrant was significantly prolonged (P0.01). Compared with the model control group, the percentage of the target quadrant was significantly longer (P0.05) than the model control group. The percentage of the target quadrant was significantly prolonged in the normal group compared with the G-CSF group. (P0.05). (3) observation of pathological ultrastructure in all regions of brain tissue of rats: routine HE staining, normal group cortex, hippocampus and other structures were complete, normal morphology, and orderly cells, distributed evenly.G-CSF treatment group cortex, hippocampus and other areas can be seen in a small number of glial cells proliferation, cell apoptosis is rare. Model control group cortical neurons damage obvious, A large number of isolated apoptotic cells were found. The hippocampal pyramidal cells were dilute, disorderly, and disrupted. At the same time, multiple cells were reduced, cytoplasm concentrated and nucleus retracted. (4) the expression of apoptosis factor Bcl-2 and Caspase-3 in the cortex and hippocampal CA1 region of rats was measured by immunohistochemistry. The positive reaction cells were counted and the positive reaction was positive. In the model control group, the expression of Bcl-2 in the cortex and hippocampal CA1 area decreased significantly (P0.05) and the expression of Caspase-3 increased significantly (P0.05). Compared with the model control group, the expression of Bcl-2 in the cortex and the hippocampal CA1 area was significantly increased (P0.05), the expression of Caspase-3 in the G-CSF group. Significantly decreased (P0.05).
To sum up, this study shows that G-CSF has a therapeutic effect on AD model rats excised by bilateral fornix fornix parachute. It can improve cognitive impairment in model rats to a certain extent, while G-CSF is expressed in the upper crust and hippocampus Bcl-2, and the anti apoptotic mechanism of Caspase-3 expression is involved in this treatment of AD model rats.
【学位授予单位】:吉林大学
【学位级别】:硕士
【学位授予年份】:2012
【分类号】:R749.16
【相似文献】
相关期刊论文 前10条
1 金丽娟;用PET及SPECT诊断Alzheimer病[J];国外医学.神经病学神经外科学分册;1994年05期
2 陈敏,史久华;有希望的Alzheimer病疫苗[J];国外医学.预防.诊断.治疗用生物制品分册;2000年06期
3 张旭,吴文源;氧化应激与Alzheimer病[J];上海精神医学;2000年03期
4 王瑞;CT使用于Alzheimer’s病[J];国外医学.神经病学神经外科学分册;1994年02期
5 王瑞;CT使用于Alzheimer’s病[J];国外医学.神经病学神经外科学分册;1994年01期
6 于慧玲!100853北京市,王鲁宁!100853北京市;老年期内分泌与Alzheimer病[J];中华老年医学杂志;2000年03期
7 德龙摘;非类固醇抗炎药治疗Alzheimer氏病[J];药学进展;1996年03期
8 刘学源;自由基与Alzheimer病[J];医学综述;2001年05期
9 胡瑞琅,史雪颖;Alzheimer病的病理学所见[J];中国老年学杂志;1997年06期
10 史振宇,史济平;脯氨酸内肽酶与Alzheimer’s病[J];中国临床药学杂志;1998年05期
相关会议论文 前10条
1 ;Application of Modeling and Simulation in Clinical Drug Development for Alzheimer's Disease[A];第十二次全国临床药理学学术会议会议论文集[C];2010年
2 ;Brain Sex Hormones and Gender Difference in Alzheimer s Disease[A];2011全国老年痴呆与衰老相关疾病学术会议第三届山东省神经内科医师(学术)论坛论文汇编[C];2011年
3 ;Therapeutic Strategies for Alzheimer Disease:Challenges and Opportunities[A];2011全国老年痴呆与衰老相关疾病学术会议第三届山东省神经内科医师(学术)论坛论文汇编[C];2011年
4 张凌芳;职晓燕;张秀丽;;55例Alzheimer病的精神症状及护理[A];河南省精神科康复护理培训班及学术研讨会论文集[C];2009年
5 Patricia V.Burgos;Gonzalo A.Mardones;Luis L.P.daSilva;Yogikala Prabhu;Juan S.Bonifacino;;Sorting and Processing of the Alzheimer's Disease Amyloid Precursor Protein Mediated by the AP-4 Complex[A];第十一次中国生物物理学术大会暨第九届全国会员代表大会摘要集[C];2009年
6 ;Elevated plasma levels of soluble tumor necrosis factor receptors in Alzheimer's disease patients[A];中国生理学会第23届全国会员代表大会暨生理学学术大会论文摘要文集[C];2010年
7 崔德华;;Implication of Aging Related Factor for Pathogenic Mechanism in Alzheimer s Disease:involving Hypoxia inducible factor and epigenemics[A];2011全国老年痴呆与衰老相关疾病学术会议第三届山东省神经内科医师(学术)论坛论文汇编[C];2011年
8 ;Fragment-based Drug Design for Multi-Target-Directed Ligand against Alzheimer's disease[A];2011年全国药物化学学术会议——药物的源头创新论文摘要集[C];2011年
9 ;Role of glycogen synathese kinase-3β in Alzheimer-like neurodegeneration[A];中国病理生理学会第九届全国代表大会及学术会议论文摘要[C];2010年
10 ;AD Images[A];2011全国老年痴呆与衰老相关疾病学术会议第三届山东省神经内科医师(学术)论坛论文汇编[C];2011年
相关重要报纸文章 前10条
1 阿胜 编译;2009医药大事件[N];医药经济报;2009年
2 本报特约撰稿人 樊平;AD领域:待挖的“金矿”[N];医药经济报;2009年
3 清小苑;AD患者后代高血压风险更高[N];医药经济报;2009年
4 刘良鸣 周玉琢;国家一类新药ZT-1显露曙光[N];医药经济报;2000年
5 何明大;防治老年痴呆中医药有优势[N];大众卫生报;2004年
6 丁莹 王旌;健康老龄化[N];中国质量报;2001年
7 龚 游;预防老年性痴呆[N];中国中医药报;2003年
8 颜乾麟;阿尔茨海默病精神行为障碍的中医治疗[N];上海中医药报;2003年
9 郭晓昕 颜敏 李少丽;国外重视儿童用药研究[N];中国医药报;2000年
10 董为柏;老年痴呆患者护理技巧[N];医药经济报;2004年
相关博士学位论文 前10条
1 毕炳添;C反应蛋白对β淀粉样蛋白生成的调节参与Alzheimer's病发病的研究[D];南方医科大学;2012年
2 陈薇;4T MR动脉自旋标记成像对早期Alzheimer病的脑灌注研究[D];天津医科大学;2011年
3 罗兰;肉苁蓉总苷对Aβ_(25-35)所致Alzheimer病的影响及其机制研究[D];新疆医科大学;2009年
4 潘晓东;减轻小胶质细胞功能紊乱可能是雷公藤氯内酯醇改善Alzheimer病淀粉样蛋白病理损害的机制[D];福建医科大学;2009年
5 王俊涛;G-CSF及褪黑素对胶质瘤细胞增殖、迁移和侵袭的影响及机制研究[D];山东大学;2012年
6 范佳;粒细胞集落刺激因子在急性脑缺血中的神经保护作用的研究[D];吉林大学;2005年
7 李德冠;P38 MAPK抑制剂联合G-CSF对全身γ射线照射小鼠辐射损伤的实验治疗研究[D];北京协和医学院;2012年
8 郭晓玲;G-CSF诱导T淋巴细胞向TH2分化的机制研究[D];中国人民解放军军医进修学院;2008年
9 姚志峰;G-CSF对压力超负荷下小鼠心室重构和心力衰竭的影响[D];复旦大学;2008年
10 曹秋云;Alzheimer病脑PET、神经心理测定及BPSD研究[D];复旦大学;2003年
相关硕士学位论文 前10条
1 李光健;G-CSF对Alzheimer病模型大鼠的治疗及其相关凋亡因子的影响[D];吉林大学;2012年
2 刘济;非霍奇金淋巴瘤血浆GM-CSF、G-CSF表达的临床意义及其与中医辨证分型的关系[D];福建中医药大学;2010年
3 杨华;G-CSF联合辛伐他汀动员血管内皮祖细胞的实验研究[D];昆明医学院;2011年
4 周江朝;应用G-CSF动员骨髓干细胞治疗重型颅脑损伤的研究[D];大连医科大学;2010年
5 姚建莉;Alzheimer病模型小鼠海马代谢物早期变化的9.4T磁共振频谱研究[D];汕头大学;2011年
6 宋磊;G-CSF对局灶脑缺血再灌注大鼠脂质过氧化及神经细胞凋亡的影响[D];吉林大学;2010年
7 金万存;脑灵汤对Alzheimer病模型鼠海马CA3区域α4NachR和α7NachR表达的影响[D];中南大学;2010年
8 王璐;新型Alzheimer病动物模型的建立[D];延边大学;2012年
9 谢晓强;G-CSF动员骨髓干细胞向缺血再灌注损伤肾脏归巢并促进肾脏修复的研究[D];天津医科大学;2011年
10 邓悦;G-CSF与EPO对血管内皮祖细胞动员作用的对比研究[D];昆明医科大学;2012年
本文编号:2012511
本文链接:https://www.wllwen.com/yixuelunwen/jsb/2012511.html